Literature DB >> 7801738

Neurovascular complications of cocaine.

M Daras1, A J Tuchman, B S Koppel, L M Samkoff, I Weitzner, J Marc.   

Abstract

Use of cocaine in the USA, has reached epidemic proportions since 1983, when "crack" was introduced, its higher potency compared with cocaine HCl has been associated with a tremendous increase in the incidence of strokes. This study reports our experience with 55 cases of neurovascular events (25 ischemic and 30 hemorrhagic) related to cocaine use in 54 patients. Only 15 patients had other risk factors for stroke. Twenty six patients smoked "crack", 10 snorted cocaine and 12 injected it intravenously. Strokes occurred within 3 h of cocaine use in 15 patients with infarcts and 17 with hemorrhages. Ten infarcts occurred after an overnight binge. Of the hemorrhage group 9 were subarachnoid, 16 intracerebral (8 basal ganglia, 7 hemispheric and one brain stem) and 5 intraventricular. Computerized tomography (CT) showed an aneurysm of the anterior communicating artery, as well as one of the vein of Galen. Four aneurysms and 3 AVMs were identified on angiography. CT revealed 15 infarcts; it was normal in 7 patients with pure motor hemiparesis and in 3 with findings consistent with anterior spinal artery infarction. Several mechanisms may be responsible for the cerebrovascular complications. A sudden rise in systemic arterial pressure may cause hemorrhages, frequently in association with an underlying aneurysm or AVM. Vasospasm, arteritis, myocardial infarction with cardiac arrhythmias and increased platelet aggregation may provoke infarcts.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7801738     DOI: 10.1111/j.1600-0404.1994.tb02691.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  17 in total

Review 1.  Street drug abuse leading to critical illness.

Authors:  Babak Mokhlesi; Prasad S Garimella; Aaron Joffe; Valerie Velho
Journal:  Intensive Care Med       Date:  2004-03-04       Impact factor: 17.440

2.  A case-control study of stroke risk factors and outcomes in African American stroke patients with and without crack-cocaine abuse.

Authors:  Elias A Giraldo; Muhammad A Taqi; Georgeta D Vaidean
Journal:  Neurocrit Care       Date:  2012-04       Impact factor: 3.210

Review 3.  Neuropsychiatric effects of cocaine use disorders.

Authors:  Charles U Nnadi; Olubansile A Mimiko; Henry L McCurtis; Jean Lud Cadet
Journal:  J Natl Med Assoc       Date:  2005-11       Impact factor: 1.798

Review 4.  Drug abuse and stroke.

Authors:  Ana Catarina Fonseca; José M Ferro
Journal:  Curr Neurol Neurosci Rep       Date:  2013-02       Impact factor: 5.081

5.  Pharmacotherapeutic strategies for treating cocaine use disorder-what do we have to offer?

Authors:  Laura Brandt; Thomas Chao; Sandra D Comer; Frances R Levin
Journal:  Addiction       Date:  2020-09-28       Impact factor: 6.526

6.  Intracerebral hemorrhage in cocaine users.

Authors:  Sheryl Martin-Schild; Karen C Albright; Hen Hallevi; Andrew D Barreto; Maria Philip; Vivek Misra; James C Grotta; Sean I Savitz
Journal:  Stroke       Date:  2010-02-25       Impact factor: 7.914

7.  Prefrontal cortical volume reduction associated with frontal cortex function deficit in 6-week abstinent crack-cocaine dependent men.

Authors:  George Fein; Victoria Di Sclafani; Dieter J Meyerhoff
Journal:  Drug Alcohol Depend       Date:  2002-09-01       Impact factor: 4.492

8.  Spastic paraparesis following cocaine inhalation.

Authors:  Henry Oluwasefunmi Savage; Malin Roesner; David Cohen
Journal:  Case Rep Med       Date:  2009-05-04

Review 9.  Cocaine use and stroke.

Authors:  Sean D Treadwell; Tom G Robinson
Journal:  Postgrad Med J       Date:  2007-06       Impact factor: 2.401

Review 10.  Evaluation of the "Pipeline" for Development of Medications for Cocaine Use Disorder: A Review of Translational Preclinical, Human Laboratory, and Clinical Trial Research.

Authors:  Paul W Czoty; William W Stoops; Craig R Rush
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.